Healthcare -
Biotechnology - NASDAQ - US
$ 8.02
-0.125 %
$ 178 M
Market Cap
-3.68
P/E
INMB - TOTAL CURRENT LIABILITIES
Total Current Liabilities INMB - INmune Bio, Inc.
18.5 M
LAST VALUE
105.82%
2 YEAR CAGR
86.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR